Abrocitinib versus dupilumab: Impact on skin barrier function and proteomics in atopic dermatitis

Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis

Emma Guttman‐Yassky, Robert Bissonnette, Benjamin Ungar et al. · Journal of Allergy and Clinical Immunology · 2018 · 678 citations · Full text

Medicine, Dermatology, Immunology +17

Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis

Andrew Blauvelt, Henrique D. Teixeira, Eric L. Simpson et al. · JAMA Dermatology · 2021 · 485 citations · Full text

Medicine, Dermatology, Pharmacotherapy +14

Transepidermal water loss reflects permeability barrier status: validation in human and rodent<i>in vivo</i>and<i>ex vivo</i>models

Joachim W. Fluhr, Kenneth R. Feingold, Peter M. Elias · Experimental Dermatology · 2006 · 258 citations

Engineering, Bioengineering, Physiology +12

Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial

Kristian Reich, Jacob P. Thyssen, Andrew Blauvelt et al. · The Lancet · 2022 · 237 citations

Life Sciences, Dermatology, Immunology +12

Skin Barrier Function in Psoriasis and Atopic Dermatitis: Transepidermal Water Loss and Temperature as Useful Tools to Assess Disease Severity

Trinidad Montero‐Vílchez, María-Victoria Segura-Fernández-Nogueras, Isabel Pérez-Rodríguez et al. · Journal of Clinical Medicine · 2021 · 197 citations · Full text

Medicine, Dermatology, Dermatopathology +14